3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
September's been a lousy month for biotech stocks with the Nasdaq Biotechnology Index down around 5.7% since the end of August. Rising interest rates are the main cause for concern, but that isn't a good reason to lose faith in this particular industry.
You could sit around feeling sad about the September sell-off, or you could take advantage of some bargain stock opportunities. Analysts on Wall Street who follow these three biotech stocks think they're trading for a lot less than they should be. Here's why they could be terrific bargains right now.
Source Fool.com